• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2009 / August / 19 / Court Approves $125 Million Settlement in Bristol-Myers Plavix Securities Class Action

Court Approves $125 Million Settlement in Bristol-Myers Plavix Securities Class Action

By Securities Docket on August 19, 2009, 12:01 pm

BristolMyersSquibbJudge Paul Crotty of the U.S. District Court for the SDNY granted preliminary approval for Bristol-Myers Squibb Co.’s settlement in the securities class action accusing it of hiding information related to a case involving its anti-blood clotting medication Plavix, Reuters reports.  Under the settlement, BMS will pay to pay $125 million.  Judge Crotty called the settlement “fair, reasonable and adequate to the class,” and scheduled a Dec. 8 hearing for final approval.

The lead plaintiff in the Bristol-Myers class-action case is the Ontario Teachers’ Pension Plan Board.

Read the Reuters article

Blog Widget by LinkWithin

Posted in Class Actions | Tagged Features, Settlements

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Ankura 260x250

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.